Walid Al-Zordk | Fixed Prosthodontics | Best Researcher Award

Assist Prof Dr. Walid Al-Zordk | Fixed Prosthodontics | Best Researcher Award

Assist Professor at Faculty of Dentistry, Mansoura University, Egypt.

Walid A. Al-Zordk is an Assistant Professor in the Department of Fixed Prosthodontics at the Faculty of Dentistry, Mansoura University, Egypt. He holds an MD and a Ph.D. in Fixed Prosthodontics, demonstrating a solid academic foundation and expertise in his field. With extensive teaching experience at several institutions, including Mansoura University and Horus University, he is dedicated to educating the next generation of dental professionals. Dr. Al-Zordk has completed nine research projects, contributing significantly to advancements in prosthodontics, and serves as the Managing Editor of the Mansoura Journal of Dentistry, where he promotes rigorous academic standards. His H-index of 8 reflects his scholarly impact, although there is potential for further growth in publication volume and industry collaboration. Overall, his commitment to research, teaching, and academic leadership positions him as a valuable asset to the dental community and a deserving candidate for the Best Researcher Award.

Profile:

Education

Walid A. Al-Zordk has a strong educational background in the field of dentistry, specifically specializing in Fixed Prosthodontics. He earned his Bachelor of Science in Oral and Dental Medicine from Mansoura University, Egypt. Following this foundational degree, he pursued a Master’s degree in Fixed Prosthodontics at the same institution, further enhancing his expertise in this specialized area. Dr. Al-Zordk continued his academic journey by obtaining a Ph.D. in Fixed Prosthodontics from Mansoura University, solidifying his position as a knowledgeable and skilled practitioner in the field. Throughout his educational experience, he has gained valuable insights and skills, which he has successfully applied in various academic roles, including his current position as an Assistant Professor in the Department of Fixed Prosthodontics at the Faculty of Dentistry. His comprehensive training and dedication to continuous learning underpin his commitment to advancing the field of prosthodontics and educating future dental professionals.

Professional Experience

Walid A. Al-Zordk is an accomplished professional with extensive experience in the field of Fixed Prosthodontics. He began his academic journey as a Clinical Demonstrator in the Department of Conservative Dentistry at Mansoura University, Egypt. His dedication and expertise led him to various roles, including Assistant Lecturer and Lecturer at multiple institutions, such as Delta University for Science and Technology and Horus University. Over the years, he has transitioned to positions of greater responsibility, becoming an Associate Professor at both Mansoura University and Horus University, where he imparts knowledge to aspiring dental professionals. In addition to his teaching roles, Dr. Al-Zordk serves as the Managing Editor of the Mansoura Journal of Dentistry, contributing to the advancement of dental research through editorial oversight. His professional journey reflects a strong commitment to education, research, and the development of innovative practices in the field of dentistry, making him a respected figure in the academic community.

Research Interest

Walid A. Al-Zordk’s research interests primarily focus on the field of prosthodontics, particularly in fixed prosthodontics. He is dedicated to exploring innovative approaches to enhance the quality and longevity of dental restorations, emphasizing the development of advanced materials and techniques that improve patient outcomes. His work investigates the mechanical and biological properties of various dental materials, aiming to understand their interactions within the oral environment. Additionally, Dr. Al-Zordk is keen on integrating digital technologies into prosthodontics, such as computer-aided design and manufacturing (CAD/CAM), to optimize the fabrication of dental prostheses. He also seeks to address challenges in the field, including the management of complex cases and the aesthetics of dental restorations. Through his research, Dr. Al-Zordk aims to contribute to evidence-based practices in dentistry and enhance the educational experience for future dental professionals.

Research Skills

Walid A. Al-Zordk possesses a robust set of research skills that enhance his contributions to the field of Fixed Prosthodontics. His expertise in clinical research methodologies enables him to design and execute studies effectively, ensuring the validity and reliability of his findings. Proficient in data analysis, he utilizes statistical tools to interpret complex datasets, thereby deriving meaningful conclusions that advance dental practices. His strong literature review skills allow him to critically evaluate existing research, identifying gaps and formulating relevant research questions. Furthermore, his experience in managing editorial responsibilities for the Mansoura Journal of Dentistry underscores his understanding of the peer review process and scholarly communication. Dr. Al-Zordk’s ability to collaborate with multidisciplinary teams fosters innovation and knowledge sharing, while his commitment to mentoring emerging researchers ensures the sustainability of academic excellence in prosthodontics. Collectively, these skills position him as a leader in dental research and education.

Award and Recognition

Walid A. Al-Zordk has garnered significant recognition throughout his academic career in the field of Fixed Prosthodontics. He has been acknowledged for his outstanding contributions to dental research, with several accolades highlighting his innovative work. His role as Managing Editor of the Mansoura Journal of Dentistry underscores his influence and dedication to advancing dental education and research. Al-Zordk has presented at various national and international conferences, earning praise for his presentations and fostering collaboration in the dental community. His scholarly contributions, reflected in his H-index of 8, demonstrate the impact of his research on peers and practitioners. Additionally, he is actively involved in mentoring aspiring researchers, further solidifying his reputation as a respected educator. These accomplishments affirm his commitment to excellence and innovation in dentistry, positioning him as a prominent figure in the field and deserving of recognition through prestigious awards.

Conclusion

In conclusion, Walid A. Al-Zordk stands out as a deserving candidate for the Best Researcher Award due to his solid academic foundation, notable research contributions, and leadership in academia. While there are areas for improvement, particularly in increasing his publication and consultancy engagements, his commitment to advancing the field of prosthodontics and his active role in educating future professionals make him a valuable asset to the academic community. His recognition through this award would not only honor his achievements but also inspire continued excellence in dental research and education.

Publication Top Notes

  • Computer vision based distributed denial of service attack detection for resource-limited devices
    • Authors: Gebrye, H., Wang, Y., Li, F.
    • Year: 2024
    • Journal: Computers and Electrical Engineering
    • Volume/Issue/Page: 120, 109716
  • Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide
    • Authors: El-Gizawy, S.A., Osman, M.A., Arafa, M.F., El Maghraby, G.M.
    • Year: 2015
    • Journal: International Journal of Pharmaceutics
    • Volume/Issue/Page: 478(2), 773-778
  • Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets
    • Authors: Arafa, M.F., El-Gizawy, S.A., Osman, M.A., El Maghraby, G.M.
    • Year: 2016
    • Journal: Drug Development and Industrial Pharmacy
    • Volume/Issue/Page: 42(8), 1225-1233
  • Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis
    • Authors: Eid, R.K., Ashour, D.S., Essa, E.A., El Maghraby, G.M., Arafa, M.F.
    • Year: 2020
    • Journal: Carbohydrate Polymers
    • Volume/Issue/Page: 232, 115826
  • Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets
    • Authors: Arafa, M.F., El-Gizawy, S.A., Osman, M.A., El Maghraby, G.M.
    • Year: 2018
    • Journal: Pharmaceutical Development and Technology
    • Volume/Issue/Page: 23(5), 454-463
  • Co-crystallization for enhanced dissolution rate of nateglinide: In vitro and in vivo evaluation
    • Authors: Arafa, M.F., El-Gizawy, S.A., Osman, M.A., El Maghraby, G.M.
    • Year: 2017
    • Journal: Journal of Drug Delivery Science and Technology
    • Volume/Issue/Page: 38, 9-17
  • Microemulsion for simultaneous transdermal delivery of benzocaine and indomethacin: in vitro and in vivo evaluation
    • Authors: El Maghraby, G.M., Arafa, M.F., Osman, M.A.
    • Year: 2014
    • Journal: Drug Development and Industrial Pharmacy
    • Volume/Issue/Page: 40(12), 1637-1644
  • Lidocaine as eutectic forming drug for enhanced transdermal delivery of nonsteroidal anti-inflammatory drugs
    • Authors: Marei, H.F., Arafa, M.F., Essa, E.A., El Maghraby, G.M.
    • Year: 2021
    • Journal: Journal of Drug Delivery Science and Technology
    • Volume/Issue/Page: 61, 102338
  • Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice
    • Authors: Elmehy, D.A., Saad, M.A.H., El Maghraby, G.M., Arafa, M.F., Soliman, N.A., …
    • Year: 2021
    • Journal: Parasitology Research
    • Volume/Issue/Page: 120(7), 2641-2658
  • Liposomes for enhanced cellular uptake of anticancer agents
    • Authors: El Maghraby, G.M., Arafa, M.F.
    • Year: 2020
    • Journal: Current Drug Delivery
    • Volume/Issue/Page: 17(10), 861-873

 

 

 

Laura Bauman | Dentistry | Best Researcher Award

Dr. Laura Bauman | Dentistry |Best Researcher Award

Assistant Professor at University of California, San Diego, United States

Dr. Laura Elizabeth Bauman, a pediatric gastroenterologist, excels in both clinical and academic settings, making her a strong candidate for the Best Researcher Award. She completed her fellowship at Cincinnati Children’s Medical Center and has been recognized with several prestigious awards, including the Arnold W. Strauss Award and the Young Investigator Travel Award. Dr. Bauman’s leadership roles include co-directing the Fecal Microbial Transplant Program and spearheading quality improvement initiatives at Rady Children’s Pediatric IBD Center. As a peer reviewer for top journals and an active member of professional organizations, she contributes significantly to the advancement of pediatric gastroenterology. Her dedication to service is evident in her work with the Crohn’s and Colitis Foundation and her leadership in fostering inclusivity at Rady Children’s Hospital. While further expanding her grant funding and publication portfolio would strengthen her profile, Dr. Bauman’s commitment to research and patient care makes her an outstanding researcher.

Profile:

Education:

Dr. Laura Elizabeth Bauman has a robust academic background, beginning with her Bachelor of Arts in Human Biology from Stanford University in 2007. She went on to earn her Medical Doctorate from the Geisel School of Medicine at Dartmouth in 2012, where she conducted research under Dr. Kari Rosenkranz. Following medical school, Dr. Bauman completed her pediatric internship and residency at the University of Utah from 2012 to 2015, with mentorship from Drs. Mark Deneau and M. Kyle Jensen. She then pursued specialized training through a Pediatric Gastroenterology, Hepatology, and Nutrition Fellowship at Cincinnati Children’s Medical Center from 2015 to 2018, working with Dr. Lee A. Denson. This extensive education, paired with her research and clinical training in leading institutions, has equipped Dr. Bauman with the expertise needed to excel in pediatric gastroenterology, with a focus on inflammatory bowel diseases and clinical research.

Professional Experience:

Dr. Laura Elizabeth Bauman’s professional experience is marked by her dedication to pediatric gastroenterology and her leadership in both clinical and academic settings. Since completing her fellowship at Cincinnati Children’s Medical Center in 2018, she has played pivotal roles at Rady Children’s Hospital in San Diego, where she co-directs the Fecal Microbial Transplant Program and leads quality improvement initiatives for pediatric inflammatory bowel disease (IBD) patients. Dr. Bauman is a key member of the hospital’s Gastroenterology Fellowship Clinical Competency Committee and collaborates on interdisciplinary projects to enhance patient care. She also serves on national committees, such as the Crohn’s and Colitis Foundation’s Pediatric Affairs Committee, contributing to the development of educational resources and clinical guidelines. A peer reviewer for top gastroenterology journals, Dr. Bauman remains actively involved in research, mentorship, and patient care, solidifying her reputation as a leader in pediatric gastroenterology.

Research Skills:

Dr. Laura Elizabeth Bauman possesses advanced research skills honed through years of focused academic and clinical inquiry in pediatric gastroenterology. Her expertise lies in inflammatory bowel diseases (IBD), where she has led and contributed to numerous research projects aimed at improving clinical outcomes for pediatric patients. Dr. Bauman’s ability to design, implement, and oversee research is demonstrated by her leadership in quality improvement initiatives, such as developing standardized care protocols for acute severe colitis at Rady Children’s Hospital. She is skilled in interdisciplinary collaboration, as shown by her work on the Fecal Microbial Transplant Program and her involvement in the creation of the Inpatient Acute Severe Ulcerative Colitis order set. Additionally, Dr. Bauman is an experienced peer reviewer for leading journals and has been recognized with awards, including the Arnold W. Strauss Award. Her capacity to blend clinical practice with research makes her an asset to the field of pediatric gastroenterology.

Award and Recognition:
Dr. Laura Elizabeth Bauman has received numerous awards and recognitions that highlight her excellence in research, clinical practice, and education. Notably, she was awarded the prestigious Arnold W. Strauss Award, a competitive $10,000 grant aimed at advancing clinical fellows’ research, specifically for her work on refractory ulcerative colitis. She also earned the Young Investigator Travel Award from the Crohn’s and Colitis Congress, recognizing her contributions to cutting-edge research in pediatric gastroenterology. In 2013, she was honored with the Golden Apple Award from the University of Utah’s Department of Pediatrics for her exceptional teaching and mentorship of medical students. Additionally, Dr. Bauman was selected as a candidate for the National Center for Leadership in Academic Medicine in 2023, a professional development program for junior faculty at UC San Diego. These accolades reflect Dr. Bauman’s commitment to advancing her field and her outstanding capabilities as both a researcher and educator.

Conclusion:

Dr. Laura Elizabeth Bauman is an outstanding candidate for the Research for Best Researcher Award, with a deep commitment to advancing pediatric gastroenterology through research, leadership, and service. While areas such as increasing her publication profile and securing larger grants could further strengthen her candidacy, her current achievements in clinical research and professional development make her a highly competitive nominee for this award.

Publication Top Notes:

  1. Mould DR, Upton RN, Wojciechowski J.
    Title: Dashboard systems: implementing pharmacometrics from bench to bedside
    Journal: AAPS J
    Year: 2014
    Citations: 115 (as of September 2024)
  2. Eser A, Primas C, Reinisch S, et al.
    Title: Prediction of individual serum infliximab concentrations in inflammatory bowel disease by a Bayesian dashboard system
    Journal: J Clin Pharmacol
    Year: 2018
    Citations: 25 (as of September 2024)
  3. Hyams J, Walters TD, Crandall W, et al.
    Title: Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension
    Journal: Curr Med Res Opin
    Year: 2011
    Citations: 229 (as of September 2024)
  4. Crombé V, Salleron J, Savoye G, et al.
    Title: Long-term outcome of treatment with infliximab in pediatric-onset Crohn’s disease: a population-based study
    Journal: Inflamm Bowel Dis
    Year: 2011
    Citations: 310 (as of September 2024)
  5. Wine E, Mack DR, Hyams J, et al.
    Title: Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis
    Journal: J Crohns Colitis
    Year: 2013
    Citations: 152 (as of September 2024)
  6. Hyams J, Crandall W, Kugathasan S, et al.; REACH Study Group
    Title: Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in children
    Journal: Gastroenterology
    Year: 2007
    Citations: 945 (as of September 2024)
  7. Merras-Salmio L, Kolho KL.
    Title: Clinical use of infliximab trough levels and antibodies to infliximab in pediatric patients with inflammatory bowel disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 62 (as of September 2024)
  8. Moore C, Corbett G, Moss AC.
    Title: Systematic review and meta-analysis: serum infliximab levels during maintenance therapy and outcomes in inflammatory bowel disease
    Journal: J Crohns Colitis
    Year: 2016
    Citations: 310 (as of September 2024)
  9. Frymoyer A, Hoekman DR, Piester TL, et al.
    Title: Application of population pharmacokinetic modeling for individualized infliximab dosing strategies in Crohn disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 63 (as of September 2024)
  10. Vande Casteele N, Khanna R, Levesque BG, et al.
    Title: The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn’s disease
    Journal: Gut
    Year: 2015
    Citations: 725 (as of September 2024)